Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
Phase 1
Recruiting
- Conditions
- Chronic Kidney Diseases
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- EHL Bio Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT06071143
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Phase 2
Active, not recruiting
- Conditions
- Atopic Dermatitis
- First Posted Date
- 2019-10-24
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- EHL Bio Co., Ltd.
- Target Recruit Count
- 118
- Registration Number
- NCT04137562
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of
🇰🇷Korea University AnSan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
🇰🇷Chung-Ang University Hospital, Seoul, Seoulteukbyeolsi, Korea, Republic of
Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: ADSTEM Inj.
- First Posted Date
- 2017-08-17
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- EHL Bio Co., Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT03252340
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of
Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: ADSTEM Inj. (Adult human mesenchymal stem cells)
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2017-12-22
- Lead Sponsor
- EHL Bio Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT02888704
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of
News
No news found